| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine
|
Kobayashi, Hirofumi
|
|
2013
|
31 |
52 |
p. 6239-6246
8 p.
|
article
|
| 2 |
Binding and cleavage (BINACLE) assay for the functional in vitro detection of tetanus toxin: Applicability as alternative method for the safety testing of tetanus toxoids during vaccine production
|
Behrensdorf-Nicol, Heike A.
|
|
2013
|
31 |
52 |
p. 6247-6253
7 p.
|
article
|
| 3 |
Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques
|
Vanloubbeeck, Yannick
|
|
2013
|
31 |
52 |
p. 6216-6224
9 p.
|
article
|
| 4 |
DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice
|
Chen, Jia
|
|
2013
|
31 |
52 |
p. 6225-6231
7 p.
|
article
|
| 5 |
Editorial Board/Aims and Scope
|
|
|
2013
|
31 |
52 |
p. CO2-
1 p.
|
article
|
| 6 |
Erratum to: “Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer” [Vaccine 30S5 (2012) F88–F99]
|
Arbyn, Marc
|
|
2013
|
31 |
52 |
p. 6266-
1 p.
|
article
|
| 7 |
Ethical analyses of institutional measures to increase health care worker influenza vaccination rates
|
Zimmerman, Richard K.
|
|
2013
|
31 |
52 |
p. 6172-6176
5 p.
|
article
|
| 8 |
Functionality of the pneumococcal antibody response in down syndrome subjects
|
Kusters, M.A.A.
|
|
2013
|
31 |
52 |
p. 6261-6265
5 p.
|
article
|
| 9 |
Haemophilus influenzae type b (Hib) Vaccination WHO position paper: July 2013-Recommendations
|
|
|
2013
|
31 |
52 |
p. 6168-6169
2 p.
|
article
|
| 10 |
How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria?
|
Thomas, Roger E.
|
|
2013
|
31 |
52 |
p. 6201-6209
9 p.
|
article
|
| 11 |
Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alum
|
de Villiers, Sabina H.L.
|
|
2013
|
31 |
52 |
p. 6185-6193
9 p.
|
article
|
| 12 |
Kinetics of influenza A virus nucleoprotein antibody (IgM, IgA, and IgG) in serum and oral fluid specimens from pigs infected under experimental conditions
|
Panyasing, Y.
|
|
2013
|
31 |
52 |
p. 6210-6215
6 p.
|
article
|
| 13 |
Phase I/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1
|
Mössler, Christina
|
|
2013
|
31 |
52 |
p. 6194-6200
7 p.
|
article
|
| 14 |
Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway
|
Steens, Anneke
|
|
2013
|
31 |
52 |
p. 6232-6238
7 p.
|
article
|
| 15 |
Rotavirus vaccines WHO position paper: January 2013 – Recommendations
|
|
|
2013
|
31 |
52 |
p. 6170-6171
2 p.
|
article
|
| 16 |
RSV vaccine in development: Assessing the potential cost-effectiveness in the Dutch elderly population
|
Meijboom, M.J.
|
|
2013
|
31 |
52 |
p. 6254-6260
7 p.
|
article
|
| 17 |
Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours
|
Wumkes, M.L.
|
|
2013
|
31 |
52 |
p. 6177-6184
8 p.
|
article
|
| 18 |
Third European Influenza Summit
|
McElhaney, Janet
|
|
2013
|
31 |
52 |
p. 6161-6167
7 p.
|
article
|
Journal description